What is Evercore ISI's price target for CAH?

Evercore ISI's latest stated price target for Cardinal Health Inc. (CAH) is $140, from its action on Jan 7, 2025.

What is Evercore ISI's rating on CAH?

Evercore ISI rates CAH Outperform, a bullish rating, as of Jan 7, 2025.

When did Evercore ISI last change its view on CAH?

On Jan 7, 2025, Evercore ISI upgrades to Outperform from In-line, price target $140.

Evercore ISI CAH price target and rating history

Cardinal Health Inc. (CAH) · Health Care

Evercore ISI rates Cardinal Health Inc. (CAH) Outperform with a $140 price target, as of its latest action on Jan 7, 2025. It has published 3 rating actions on CAH since May 2022, including 2 upgrades and 1 downgrade.

Current rating: Outperform
Price target: $140
Median target, all firms: Too few
Actions on CAH: 3

Evercore ISI price target on CAH

Evercore ISI price target on CAH, each point a stated target, May 2022 to January 2025.

Every Evercore ISI rating on CAH

Jan 7, 2025
UpgradeEvercore ISI upgrades to Outperform from In-line, price target $140
Jul 10, 2023
DowngradeEvercore ISI downgrades to In-line from Outperform, price target $100
May 18, 2022
UpgradeEvercore ISI upgrades to Outperform from In-line, price target $55 to $68

How other firms rate CAH

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
RBC Capital Markets	Outperform	$276	Aug 19, 2026
William Blair	Outperform		Apr 28, 2026
Citigroup	Buy		Jan 9, 2026
Barclays	Overweight	$243	Dec 9, 2025

Questions about Evercore ISI and CAH

What is Evercore ISI's price target for CAH?: Evercore ISI's latest stated price target for Cardinal Health Inc. (CAH) is $140, from its action on Jan 7, 2025.
What is Evercore ISI's rating on CAH?: Evercore ISI rates CAH Outperform, a bullish rating, as of Jan 7, 2025.
When did Evercore ISI last change its view on CAH?: On Jan 7, 2025, Evercore ISI upgrades to Outperform from In-line, price target $140.

More CAH rating histories

All Evercore ISI ratings CAH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.